Browsing Category
Featured Articles
VCCN and Alliance Cancer Specialists aspire to offer Oncology Care across Philadelphia
Vantage Cancer Care Network into providing integrated cancer Care ventured into an agreement with Alliance Cancer Specialists, PC ensuring extensive delivery of top-notch Oncology Care…
Read More...
Read More...
START collaborates with Sarah Cannon to accelerate Phase I drug development programs
Sarah Cannon Research Institute and South Texas Research Accelerated Therapeutics moved to collaborate ensuring augmenting their globally acclaimed phase I drug development programs…
Read More...
Read More...
GE Healthcare and Roche partners to develop digital Clinical Solutions
Utilizing advanced analytics to offer workflow solutions and apps that advocate support solutions paving way for undisputed integration and analysis of in-vivo and in-vitro data, …
Read More...
Read More...
US Diagnostics declares availability of INFINITY Blood Glucose Monitoring System across Western…
U.S Diagnostics confirms distribution of the INFINITY Blood Glucose Monitoring System across Western Africa. Located in New York, INFINITY Blood Glucose Monitoring System…
Read More...
Read More...
USRM alleges 10,000 kit sales of Adipocell product
U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...
Read More...
CCP confirms testification of IGA scale for treating EBS
Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...
Read More...
Fresenius Kabi Launches Bortezomib injection in U.S
Fresenius Kabi confirmed the availability of Bortezomib for injection in the United States. Fresenius Kabi Bortezomib for Injection is available as a single dose vial containing 3.5 mg…
Read More...
Read More...
FDA approves GSK’s FLUARIX QUADRIVALENT
GSK asserted that it has received approval from the US FDA center for biologics Evaluation and Research thereby hinting at the usage of FLUARIX QUADRIVALENT in persons 6 months and…
Read More...
Read More...
SkinCure Oncology delivers 46th image guided superficial radiation therapy system
SkinCure Oncology declared delivery of its 46th image guided superficial radiation therapy system. SkinCure Oncology is into providing a turnkey model for delivery of such systems.…
Read More...
Read More...
WaveForm Technologies Finishes Four Human Clinical Trials for CGM System
This is to be brought to notice that WaveForm Technologies has successfully completed its four clinical Trials for its proprietary continuous glucose monitoring system.
Patients are…
Read More...
Read More...
Armando Moncada Entitled Chief Medical Officer by Aeon Global Health
Aeon global health asserts that Armando Moncada, MD, FCAP appointed as its Chief medical officer of its Anatomy Pathology business line ushering in on board 20 years of expertise and…
Read More...
Read More...
Kalorama escalates IVD innovations to combat Sepsis
Kalorama states that IVD industry has embarked on an approach to advance IVD innovations in Sepsis. Sepsis is characterized by tedious detection in its early stages as fever,…
Read More...
Read More...
AstraZeneca declared availability of BYDUREON BCise for Type-2 Diabetes
AstraZeneca declared that BYDUREON BCise was now available in pharmacies across the U.S. An injectable suspension 2mg sanctioned by the U.S FDA for adults afflicted with Type-2 Diabetes…
Read More...
Read More...
GT Biopharma completes dosing in Phase 1 Clinical Trial for GTP-004 to treat Myasthenia Gravis
GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...
Read More...
Aerin to rollout VIVAER for overcoming nasal airway obstruction
It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...
Read More...
PharmaMar Pronounces a distribution license agreement with Megapharm
PharmaMar enters into a distribution license agreement with Megapharm for the commercialisation of anticancer drug Aplidin (plitidepsin) in Israel derived from marine.
As per the…
Read More...
Read More...
Liquidia Technologies undertakes Phase 3 Clinical Trial of LIQ861 for Diagnosing PAH
Clinical biopharmaceutical company, Liquidia dedicated to accelerate the performance of precision medicine by accurately engineering drug particles announces to commence the evolution…
Read More...
Read More...
I-Mab Biopharma signs licensing agreement for HyLeukin with Genexine
HyLeukin is an immuno-oncology agent comprised of an optimally engineered Interleukin-7 (IL-7) molecule based on Genexine's proprietary long-acting platform technology. Genexine…
Read More...
Read More...
Mallinckrodt to acquire Sucampo Pharmaceuticals for approximately $1.2 Billion
Mallinckrodt announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets. The transaction was…
Read More...
Read More...
Teva Announces Exclusive Launch of a Generic Version of Reyataz in the U.S.
Teva Pharmaceutical Industries Ltd., announced the exclusive launch of a generic version of Reyataz®1 (atazanavir) capsules in the U.S.
Atazanavir sulfate capsules are a protease…
Read More...
Read More...